The most commonly mutated genes in pancreatic neuroendocrine tumors (PanNETs) are ATRX, DAXX, and MEN1. Little is known about the cells-of-origin for non-functional neuroendocrine tumors. Here, we genotyped 64 PanNETs for mutations in ATRX, DAXX, and MEN1 and found 37 tumors (58%) carry mutations in these three genes (A-D-M mutant PanNETs) and this correlates with a worse clinical outcome than tumors carrying the wild-type alleles of all three genes (A-D-M WT PanNETs). We performed RNA sequencing and DNA-methylation analysis on 33 randomly selected cases to reveal two distinct subgroups with one group consisting entirely of A-D-M mutant PanNETs. Two biomarkers differentiating A-D-M mutant from A-D-M WT PanNETs were high ARX gene expression and low PDX1 gene expression with PDX1 promoter hyper-methylation in the A-D-M mutant PanNETs. Moreover, A-D-M mutant PanNETs had a gene expression signature related to that of alpha cells (pval < 0.009) of pancreatic islets including increased expression of HNF1A and its transcriptional target genes. This gene expression profile suggests that A-D-M mutant PanNETs originate from or transdifferentiate into a distinct cell type similar to alpha cells.
Introduction
Pancreatic neuroendocrine tumors (PanNETs) or Islet Cell Tumors are a rare neuroendocrine malignancy with an annual incidence of less than 1 per 100,000 per year 1 (about 1,000 new cases per year in the United States  3 cases per million.) Current classification scheme for PanNETs include grade and stage 1 . While well-differentiated PanNETs can be successfully treated with surgery, there are few treatments for metastatic PanNETs. A greater understanding of PanNET pathogenesis may guide the development of novel therapeutic options.
Molecular studies have identified mutations in MEN1, ATRX, and DAXX to be the most commonly found in PanNETs 2,3 (found in approximately 10, 20 and 40% of tumors, respectively).
All three genes play a role in chromatin remodeling. MEN1 is a component of a histone methyltransferase complex 4 that specifically methylate Lysine 4 of histone H3 and functions as a transcriptional regulator. ATRX and DAXX interact to deposit histone H3.3-containing nucleosomes in centromeric and telomeric regions of the genome 5 . Additional mutations in mTOR pathway genes including TSC2, PTEN, and PIK3CA are found in one in six welldifferentiated PanNETs 2 .
Most PanNETs are classified as nonfunctional as they do not cause any symptoms until later stages of tumorigenesis, while a minority cause symptoms due to excessive secretion of hormones and are thus functional. The neuroendocrine cells in the pancreas include alpha, beta, delta, pancreatic polypeptide (pp)-producing and vasoactive intestinal peptide (VIP)-producing cells.
The cell of origin for nonfunctional PanNETs is not well established. Here, we genotyped 64 well differentiated PanNETs for mutations in ATRX, DAXX and MEN1 and performed RNA sequencing (n=33) and DNA methylation (n=32) analysis to identify distinct molecular phenotypes of A-D-M mutant PanNETs which potentially reveals their distinct cell of origin or transdifferentiated state.
Results

Patient cohort, clinical annotation, and genotyping for ATRX, DAXX and MEN1
We initially performed targeted sequencing to genotype the ATRX, DAXX and MEN1 genes in 64 individual PanNETs. All cases were histologically confirmed to be well-differentiated PanNETs of WHO G1/G2 grade, and cases of poorly differentiated neuroendocrine carcinoma were excluded. The mean patient age was 52±1.5 years (ranging from 26-73) with a 59% male population. The locations of the tumors were 38% proximal/mid body, and 62% distal pancreas.
Eighty-one percent of the cases were clinically non-functional and the remaining cases included insulinomas, glucagonomas, gastrinomas, and VIPomas. The median size of tumor was 3.6±0.4 cm (ranging from 1.0 -14.5 cm). Sixty-eight percent of patients had localized disease without distant metastasis at the time of initial diagnosis (Supplementary file 1).
An A-D-M mutant genotype was identified in 58% (37/64) of cases with ATRX, DAXX, MEN1, MEN1/ATRX, and MEN1/DAXX mutations in 8%, 16%, 20%, 3%, and 11% cases, respectively ( Figure 1a ). Among 44 patients who initially presented with localized disease without distant metastasis, those with the A-D-M mutant genotype had a worse recurrence free survival than those of A-D-M WT genotype (Figure 1b ).
Gene expression and DNA methylation reveal two subtypes of PanNETs
We performed RNA sequencing on 33 tumors by random selection ( Supplementary Fig 2) . These data show that A-D-M mutant tumors have a distinct gene expression pattern from that of A-D-M WT PanNETs. Neither hierarchical clustering nor PCA from gene expression revealed further subgrouping of the tumors with single mutations in ATRX, DAXX, or MEN1 or double mutations in ATRX/MEN1 or DAXX/MEN1.
In hierarchical clustering, the A-D-M mutant PanNETs formed a tighter cluster than the A-D-M WT PanNETs. In PCA, the A-D-M mutant PanNETs had smaller variance along PC1 than A-D-M WT PanNETs. Pair-wise correlation of gene expression between all PanNETs, showed a higher correlation among A-D-M mutant PanNETs as compared to A-D-M WT PanNETs ( Figure   2c ). Among A-D-M mutant PanNETs, mutants with the same genotype (mutations in ATRX/DAXX/MEN1) did not show greater gene expression correlation. These data suggest that A-D-M mutant PanNETs are a more homogeneous group compared to A-D-M WT PanNETs.
Within A-D-M mutant or A-D-M WT PanNETs groups, unsupervised clustering and PCA did not reveal differences between primary and metastatic tumors. Top 100 genes with highest variance across all samples separates mutant from A-D-M WT PanNETs and showed relatively high expression of "liver-specific" genes (APOH, ALDH1A1, FGB, APOC3 etc.) as well as complement and coagulation pathway genes (SERPINA1, FGA, F10, CP, MT3 etc.) in A-D-M mutant PanNETs (Figure 2d ; Supplmentary Fig 3) . The pathological estimate of tumor purity was over 80% for all samples of PanNETs, suggesting that the liver gene signature was not caused by liver contamination. Seven A-D-M mutant and one A-D-M WT PanNETs were from the tissue of liver metastases and they had gene expression profile most similar to the genotype group of their primary PanNET counterpart ( Figure 2d ). We validated the distinct gene expression signature of A-D-M mutant in a larger tumor set (47 PanNETs including the 33 PanNETs where RNA sequencing was performed) using gene expression microarray technology. The 14 additional samples are comprised of 3 A-D-M WT PanNETs and 11 A-D-M mutant PanNETs (7 MEN1 mutant, 2 DAXX mutant, and 2 DAXX/MEN1 mutant)( Supplementary Fig 4) .
To investigate epigenetic differences between PanNETs, we used the Illumina 450K chip to 
A-D-M mutant PanNET gene expression resembles that of alpha cells
There are multiple neuroendocrine cell types in the pancreas including alpha, beta, gamma, delta, and epsilon. We used gene expression data for these various pancreatic neuroendocrine and exocrine cell types from a single cell sequencing study 6 ( Supplementary Table 1 ) to identify gene-set signatures representing highly expressed cell-type-specific genes (Supplementary file 2).
The A-D-M mutant PanNETs uniformly exhibited a gene expression signature that was very similar to that of alpha cells (Figure 4a ). The A-D-M WT PanNETs were more heterogeneous in their expression of the genes among the gene set signatures for the different pancreatic neuroendocrine cell types. Greater heterogeneity of gene expression signature in A-D-M WT PanNETs was consistent with the greater heterogeneity found in global gene expression.
To further investigate the gene expression signature of A-D-M mutant PanNETs we performed gene set enrichment analysis 7 (GSEA) on the thirteen manually curated gene sets for pancreatic endocrine and exocrine cells from a previous study. This study assessed gene expression of individual pancreatic cell types (alpha, beta, delta, PP, acinar, ductal, mesenchyme and endothelial) enriched by flow cytometry and single cell RNAseq ( Supplementary Table 1 ). Our analysis indicates that that only the alpha cell gene was significantly enriched in A-D-M mutant PanNETs (p-value < 0.009) ( Figure 4b and c)( Supplementary table 2 ).
Alpha and beta cell lineage specific genes were examined for the A-D-M mutant and WT PanNETs. ARX, IRX2, and TM4SF4 were all highly expressed in A-D-M mutant PanNETs compared to A-D-M WT PanNETs ( Supplementary Fig 6) . Surprisingly, GCG (glucagon) expression was lower in A-D-M mutants as compared A-D-M WT PanNETs. For beta cell specific genes, PDX1, MAFA, INS, and DLK1, all had lower expression in A-D-M mutant PanNETs than A-D-M WT PanNETs ( Supplementary Fig 6) . However, these genes had much greater expression heterogeneity in A-D-M WT PanNETs suggesting that some A-D-M WT PanNETs resemble beta cells and others did not ( Supplementary Fig 6) .
HNF1A pathway is transcriptionally up-regulated in A-D-M mutant PanNETs and alpha cells
HNF1A is one of the most significantly differentially expressed genes between A-D-M mutant and WT PanNETs. HNF1A is a homeobox family transcription factor that is highly expressed in the liver and is involved in the regulation of several liver-specific genes. The expression of (Figure 5b ; Supplementary file 3). The differentially expressed genes were also enriched for HNF1A transcription factor motifs in their promoters (FDR < 0.001, Figure 5c ). The complete list of significant TFs motif is present in Supplementary file 3. Taken together, the A-D-M mutant PanNETs had higher expression of HNF1A along with many of its transcriptional target genes associated with liver function. In addition, the transcriptional regulator of HNF1A, HNF4A 8 was expressed 3.02 fold higher in A-D-M mutant PanNETs (pvalue < 0.009). We used gene expression data from Bramswig et al 9 to show HNF1A expression was increased in alpha cells compared to beta cells (p-value < 0.008), and the 465 alpha cell specific genes in the pancreas were enriched for transcriptional targets of HNF1A and for having HNF1A TF motif in their promoters (See Methods section; Supplementary Table 3 ).
Many of the most differentially expressed genes and highly expressed in A-D-M mutant
PanNETs are targets of HNF1A and are involved in protein secretion, transport and metabolism (APOH, ALB, AFM, HAO1, UGT1A3, UGT1A1, GC, G6PC, TM4SF4, PKLR etc). APOH is expressed 8.46 fold higher in A-D-M mutant PanNETs (p-value < 10 -5 ) and is potentially a good diagnostic biomarker for A-D-M mutant PanNETs. We perform IHC staining for APOH and show positive staining in 70±2.5% of A-D-M mutant and only 18±2.0% of A-D-M WT PanNETs ( Supplementary Fig 7 and Supplementary file 1). Of the 287 differentially methylated genic CpG sites, 70 (associated with 59 genes) were found between 1500 bp 5' to transcriptional start site (TSS) and 200 bp 3' to TSS or within first exon, a region where DNA methylation is associated with transcriptional repression 10 . Thirteen of the 59 genes were also found to be differentially expressed (with fold change greater than 3 and corrected p-value < 0.05, see Methods section) and seven genes that were hypomethylated in A-D-M mutant and over-expressed are APOH, CCL15, EMID2, PDZK1, HAO1, BAIAP2L2, and NPC1L1. One gene, TACR3, was hypomethylated in A-D-M WT and over-expressed 
The PDX1 gene is more highly methylated and expressed at lower levels in A-D-M mutant
PanNETs
DNA methylation differences between the A-D-M mutant and
Discussion
Here, we found that A-D-M mutant PanNETs form a distinct subgroup on the basis of their gene expression profile and DNA methylation pattern. Moreover, this subgroup is more homogeneous based on gene expression profile than the A-D-M WT PanNETs. The gene signature of the A-D-M mutant PanNETs strongly corresponds to the genes that are specifically expressed in alpha cells including genes known to define alpha cells such as ARX and "liver-specific" genes such as HNF1A and its transcriptional targets. Conversely, PDX1, a gene critical to the beta cell lineage is transcriptionally repressed in A-D-M mutant PanNETs and the PDX1 promoter is hypermethylated. On the other hand, WT PanNETs have heterogeneous gene expression profiles and their gene mutational landscape is less understood.
The pancreas is comprised of many different cell types including acinar, ductal, and at least five but the functional tumors were insulinoma and VIPoma, even though their gene expressions have alpha cell signature. In other mouse models of PanNETs 12, 13 , MEN1 deletion using the insulin or PDX1 promoter driven Cre construct, insulinomas and well differentiated PanNETs were also observed. However, Cre expression may be leaky in these models and further study is needed to understand the heterogeneity of the cells in the tumors that develop and trace the cell of origin or transdifferntiated state of the cancer cells.
In our gene expression analysis, we have not identified the oncogenic pathways activated in A-D-M mutant PanNETs. MEN1 has been shown to upregulate expression of long noncoding RNA MEG3 in MIN6 mouse insulinoma cell line 15 . In the same study, they show MEG3 represses expression of the oncogene MET leading to delayed cell cycle progression and reduced cell proliferation. In a different study, MEN1 and DAXX were shown to repress the expression of the membrane metalloendopeptidase (MME) and mutations in MEN1 or DAXX result in loss of this repression leading to neuroendocrine tumor proliferation 16 . Our data is consistent with these studies when comparing A-D-M mutant to WT PanNETs, showing that A-D-M mutant PanNETs have lower expression of MEG3 (7.3 fold lower, p-value < 4.3E-07), higher expression of MET (3 fold higher, p-value < 0.003), and higher expression of MME (4 fold higher, p-value < 0.001). 
Method and Materials
Patient's information
Retrospective and prospective reviews of well-differentiated, pancreatic neuroendocrine neoplasms were performed using the pathology files and pancreatic database at MSKCC with IRB approval. All patients were evaluated clinically at our institution with confirmed pathologic diagnoses, appropriate radiological and laboratory studies, and surgical or oncological management. Follow-up information was obtained for all cases. 
Tissue acquisition and nucleotide extraction
Sanger sequencing for gene mutation
All exons of the DAXX, ATRX, and MEN1 genes were amplified by PCR and then sequenced conducted to elucidate subtypes structure using top 3000 variant genes as input. To query robustness of this subtyping, multiple variant gene sets were used and repeated the same process of unsupervised clustering. Top 100 variable genes were used to find genes, which were highly expressed in each subtype. Subset of these genes is selected to show in figure 2d for liver and complement system genes. To find differentially expressed genes (DEgenes) between mutant and wild-type panNETs, we used DeSeq2 R package 21 on raw count (values from RSEM). We used significance cutoff with greater than 3 fold change and corrected p-value < 0.05 to call a gene as DEgene. GSEA Preranked 7 method was used on DEgenes to find significant KEGG pathways, motif and biological process.
Clustering and Principal Component Analysis
For unsupervised clustering on log2TPM, we used Pearson distance metric and ward.D2 hclust method(unless stated otherwise). PCA analysis was done using prcomp in R. R (http://www.rproject.org/) was used for all the analysis and visualization of data.
Pancreatic Endocrine and Exocrine gene set (PEEGset) from published dataset 6,9,17
The neuroendocrine cells in the pancreas include alpha, beta, delta, pancreatic polypeptide (pp)producing and vasoactive intestinal peptide (VIP)-producing cells. Gene sets representing different endocrine islet and exocrine pancreatic cells (PEEGset) were obtained from three metadata 6, 9, 17 (supplementary Table 1 ). We created 13 PEEGset representing all major cells from endocrine and exocrine pancreases. Supplementary Table 1 shows these gene sets with major cell types and number of genes in each set. These gene set were used as prior defined gene set for GSEA analysis.
Gene Set Enrichment Analysis on Major Islets cell types
Gene Set Enrichment Analysis 7 (GSEA) was performed on the log2TPM expression values of all samples using downloaded version of GSEA software (Broad Institute, Cambridge, MA, USA) to identify the statistically enriched gene sets between A-D-M mutant and A-D-M WT PanNETs.
Published pancreatic islet endocrine and exocrine cells signatures were used as prior defined sets as an input. We used all default parameters to perform GSEA on this gene sets to determine the enrichment of specific cell signature enrichment in the panNET subtypes. We ran GSEA on 1000 permutation mode on phenotypic label to generate FDR and enrichment score (ES) for each gene set. Significant gene set was filtered based on FDR q-values (cutoff of 0.05).
Bramswig et al 9 FACs sorted normal alpha and beta cells gene expression
We extensively used Bramswig et al 9 FACs sorted RNAseq data to understand normal alpha and beta cells and correlated their gene signature sets with our A-D-M mutant and A-D-M WT panNETs. We downloaded supplement file for total RNA seq normalized expression data for alpha (3 replicate) and beta (3 replicate) and exocrine cells (2 replicate). Bramswig et al 9 provide strong genes associated with alpha, beta and exocrine cells as supplement file. We used this strong cell specific genes and created gene set for alpha, beta and exocrine and named as Bramswig_et_al gene set. HNF1A gene expression values were fetched to check whether HNF1A is over expression in normal alpha as compared to beta and exocrine. We applied Student ttest's between three alpha and three beta samples to calculate p-value for HNF1A gene expression.
Bramswig et al strong alpha cell genes (n=465) were queried to check for HNF1A transcription factor motif enriched using online GSEA version (C3 TFs motif database).
Microarray Gene expression analysis
RNA extracted from PanNETs samples were submitted for Affymetrix microarray profiling using chip hgu133a2 array. All following analysis was done in R. Briefly, the raw Affymetrix CEL files were loaded in R (simpleaffy 22 ). Normalized expression values were calculated by the GC Robust
Multi-array Average (GCRMA 23 ) algorithm and subjected to mean transformation in order to collapse all probes to respective genes in R using collapseRow 24 . We then followed the same clustering and PCA procedure that were done on RNAseq expression data. Collapsed average gene expression values were imported in GSEA to run against 13 PEEGset cell types to find enrichment. 
450K DNA methylation array analysis
Immunohistochemistry (IHC)
A representative, formalin-fixed, paraffin-embedded tissue section (4 μm thick) of each case was submitted to our institution's core facility to perform immunohistochemistry-using antibodies recognizing the APOH proteins. Briefly, sections were de-paraffinized and pre-treated in Cell 
Statistical Analysis
Data are represented as mean ± standard deviation. GraphPad Prism 6 (GraphPad Software Inc, La Jolla, Ca) was used for statistical and survival analyses. Survival analysis p-values (2-sided) were based on log-rank tests. Significance was defined as P < 0.05.
four different gene set (Var10000, Var5000, Var1000 and var500) shows robust subtyping.
Var10000 is a gene set with 10000 top variable gene based on gene expression across all samples.
All four gene set show robust stratification of A-D-M mutant (in red) from A-D-M WT (in blue)
PanNETs.
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